1. Influence of malaria on the serum levels of vitamin A, zinc and calcium of children in Douala-Cameroon
African Journal of Biotechnology Vol.6(7),pp.871-876,2 April 2007

2. Low interleukin-12 activity in severe Plasmodium falciparum malaria.
Infect Immun. 2000 Jul;68(7):3909-15.

3. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Antimicrob Agents Chemother. 1999 Sep;43(9):2205-8.

4. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria.
J Infect Dis. 1999 Jun;179(6):1584-6.

5. The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
Clin Infect Dis. 1999 Apr;28(4):794-9

6. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children.
J Infect Dis. 1999 Apr;179(4):980-8.

7. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.
Eur Cytokine Netw. 1998 Dec;9(4):639-46.

8. No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection.
Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):478-81.

9. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of  sulfadoxine/pyrimethamine or mefloquine alone.
Am J Trop Med Hyg. 1998 May;58(5):619-24

10. Protection of mice previously infected with Plasmodium vinckei against subsequent Salmonella enteritidis infection is associated with nitric oxide production capacity.
Parasitol Res. 1998;84(1):63-8

11. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon.
Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):110-4.

12. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria.
Lancet. 1998 Jan 24;351(9098):265-6.

13. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon.
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):719-24.

14. Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon.
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):578-9.

15.  [The dual role of tumor necrosis factor (TNF) during a malarial attack]
Sante. 1997 Jul-Aug;7(4):271-4. Review. French.

16. Plasmodium falciparum: inhibition of erythrocyte rosette formation and detachment of rosettes by pentoxifylline.
Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):74-5

17. Clinical diagnosis of malaria: can the patients help us improve?
Trans R Soc Trop Med Hyg. 1996 Jan-Feb;90(1):42.

18. Upregulation of ICAM-1, IL-1 and reactive oxygen intermediates (ROI) by exogenous antigens from Plasmodium falciparum parasites in vitro, and of sICAM-1 in the acute phase of malaria.
 J Chemother. 1995 Oct;7(5):424-6.